Wells Fargo’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-27
| Closed | -$5 | – | 7665 |
|
|
2024
Q1 | $5 | Buy |
27
+9
| +50% | +$4 | ﹤0.01% | 7398 |
|
|
2023
Q4 | $20 | Buy |
18
+10
| +125% | +$14 | ﹤0.01% | 7230 |
|
|
2023
Q3 | $15 | Buy |
8
+6
| +300% | +$32 | ﹤0.01% | 7302 |
|
|
2023
Q2 | $14 | Hold |
2
| – | – | ﹤0.01% | 7385 |
|
|
2023
Q1 | $47 | Buy |
+2
| New | +$97 | ﹤0.01% | 7128 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7149 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7608 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7719 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8052 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8001 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6837 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6773 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6788 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7179 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7067 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6977 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6972 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6635 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6624 |
|
|
2017
Q4 | – | Sell |
-1
| Closed | -$7.03K | – | 6580 |
|
|
2017
Q3 | $6K | Hold |
1
| – | – | ﹤0.01% | 5994 |
|
|
2017
Q2 | $10K | Hold |
1
| – | – | ﹤0.01% | 5788 |
|
|
2017
Q1 | $14K | Buy |
+1
| New | +$18.1K | ﹤0.01% | 5792 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6490 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6387 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6384 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6495 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6470 |
|
|
2015
Q3 | – | Sell |
-1
| Closed | -$18.6K | – | 6509 |
|
|
2015
Q2 | $32K | Buy |
+1
| New | +$24.4K | ﹤0.01% | 5460 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6408 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6464 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 5738 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6331 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 6124 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 5975 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 5887 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 5728 |
|
Other funds holding BIOL
Wells Fargo's BIOL Position: Q2 2024 in Review
Wells Fargo sold out of Biolase, Inc. (BIOL) in Q2 2024, closing a stake of 27 shares — an estimated $5 sold.
Wells Fargo first reported a position in BIOL in Q2 2015 and held it in 9 quarters. The position peaked at $32K in Q2 2015. 2 funds tracked by Wall St. Rank hold BIOL as of Q2 2024.
- Wells Fargo reported no remaining Biolase, Inc. position as of Q2 2024 after selling out during the quarter.
- Wells Fargo sold 27 Biolase, Inc. shares in Q2 2024, an estimated $5.
- Wells Fargo first reported a position in Biolase, Inc. in Q2 2015 and held it in 9 quarters.
- Wells Fargo's Biolase, Inc. position peaked at $32K in Q2 2015.
- 2 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2024.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.